Silk Fibroin–Ce6 Electrospun Films Enable Antibacterial PDT for Wounds

Study Background and Research Question

Bacterial infections, particularly those involving antibiotic-resistant strains such as Staphylococcus aureus, remain a critical challenge in clinical wound management. Conventional antibiotics are increasingly limited by the emergence of multidrug resistance and the protective effects of bacterial biofilms. Recent advances in photodynamic antibacterial therapy (PDAT) have highlighted the potential of light-activated photosensitizers to generate reactive oxygen species (ROS) that damage microbial cells and biofilms. However, the rapid metabolism and sometimes poor biocompatibility of small-molecule photosensitizers hinder their effectiveness in vivo. The reference study (Li et al., 2024) addresses these limitations by integrating a second-generation photosensitizer, Chlorin e6 (Ce6), into aligned silk fibroin nanofiber scaffolds. The central research question is whether this engineered biomaterial can deliver effective, biocompatible antibacterial action and support wound healing in the context of S. aureus infection.

Key Innovation from the Reference Study

The primary innovation reported by Li et al. (2024) is the fabrication of an anisotropic silk fibroin film functionalized with Ce6-conjugated electrospun nanofibers (termed SFCF@Film). This composite leverages the alignment of silk fibroin fibers to guide cellular orientation and uses covalently attached Ce6 to enable targeted ROS generation under near-infrared (NIR) irradiation. This dual-function scaffold achieves both physical and photochemical antibacterial effects while promoting tissue regeneration, representing a significant advance over traditional dressings and standalone photosensitizer solutions.

Methods and Experimental Design Insights

The research team employed a multi-step fabrication process. Silk fibroin was extracted and purified from silkworm cocoons, then electrospun into aligned nanofibers. Ce6 was chemically conjugated to the fibroin fibers, ensuring stable integration and effective photodynamic activity. The functionalized nanofibers were layered onto a silk fibroin film substrate, creating the anisotropic SFCF@Film composite. Characterization included mechanical testing, hemocompatibility assays, and ROS generation measurements under NIR light. Antibacterial efficacy was assessed in vitro against S. aureus, while in vivo experiments evaluated wound healing and immune modulation in infected mouse models (Li et al., 2024).

Protocol Parameters

• Ce6 conjugation: Covalent attachment to silk fibroin nanofibers; precise chemistry detailed in the reference protocol.
• Electrospinning conditions: Optimized to produce aligned nanofibers, supporting directional cell growth.
• NIR irradiation: 10-minute exposure post-application; ROS generation measured to confirm photodynamic activity.
• In vivo wound model: S. aureus-infected mouse wounds treated with SFCF@Film, with and without NIR irradiation, to assess antibacterial efficacy and tissue response.

Core Findings and Why They Matter

The SFCF@Film scaffold demonstrated several impactful outcomes:

• Rapid Antibacterial Action: Under NIR irradiation, Ce6-conjugated nanofibers produced high levels of ROS, resulting in efficient S. aureus eradication within 10 minutes (Li et al., 2024). This rapid effect is critical for timely infection control and biofilm disruption.
• Enhanced Biocompatibility: The silk fibroin matrix maintained desirable hemocompatibility and mechanical integrity, supporting its use as a wound dressing.
• Guided Cell Growth: The anisotropic (aligned) structure provided a directional cue for cell migration and proliferation, potentially accelerating tissue repair.
• Immunomodulation: Notably, SFCF@Film promoted M2 polarization of macrophages in vivo, associated with anti-inflammatory responses and improved wound healing outcomes. This suggests an additional benefit beyond direct antibacterial action, facilitating tissue regeneration in infected wounds.

The combination of targeted ROS generation, physical guidance of cells, and immune modulation positions this biomaterial as a promising alternative to conventional wound care approaches, especially in cases complicated by antibiotic resistance.

Comparison with Existing Internal Articles

Several recent internal reviews and research digests address related advances in the field:

• The summary "Electrospun Silk Fibroin–Ce6 Films Enable Antibacterial PDT for Wound Healing" corroborates the reference study, emphasizing the dual antibacterial and immune-supportive role of aligned silk fibroin–Ce6 films.
• "Chlorin e6 Photosensitizer: Precision Workflows for PDT Success" describes broader applications of Ce6 photosensitizer in cancer research photodynamic therapy and emerging antibacterial strategies, providing additional mechanistic context for ROS-mediated cytotoxicity and immune modulation.
• "Anisotropic Silk Fibroin–Ce6 Films Enable Antibacterial PDT in Wound Healing" presents similar findings on rapid infection clearance and beneficial macrophage polarization, reinforcing the translational potential of this approach.

Compared to earlier PDT methods using free Ce6 or other photosensitizers, the scaffold-based delivery system described by Li et al. offers superior localization, stability, and sustained activity, as well as additional regenerative cues due to its anisotropic architecture.

Limitations and Transferability

While the results are compelling, several limitations should be considered:

• Translational Maturity: The study demonstrates efficacy in mouse models, but further research is needed to confirm safety, scalability, and performance in larger animals or humans. The wound healing environment in humans may present additional challenges not captured in preclinical experiments.
• Photosensitizer Stability and Release: Covalent conjugation minimizes leaching, but the long-term fate of Ce6 and potential degradation products warrants further study.
• Specificity Against Other Pathogens: The antibacterial activity was validated against S. aureus; broader-spectrum testing is required for wounds colonized by mixed microbial populations.

Nevertheless, the approach is promising for translation to advanced wound dressings, particularly where conventional antibiotics are ineffective.

Research Support Resources

Researchers aiming to reproduce or extend this work can obtain high-purity Chlorin e6 (Ce6) (SKU B8314), a widely used photosensitizer in anticancer and antibacterial photodynamic therapy, from APExBIO. This Ce6 product is supplied with rigorous purity control and is soluble in DMSO, supporting a variety of in vitro and in vivo experimental workflows. For further exploration of protocol design, consult the reference study and related internal reviews on silk fibroin–Ce6 composites and photodynamic antibacterial strategies.